Biomarkers play an integral role in new drug development by providing valuable information to facilitate the decision-making process for new therapies. Biomarker-based stratification can be used to enrich clinical populations, reducing cost and trial duration. Drawing from years of experience as pioneers in the field of clinical biomarker science, Inotiv provides guidance to help you better understand what your data means for your program and how it can be applied to advance your therapeutic along its development pipeline.
Our scientists are experts in finding the optimum analytical strategy for biomarker detection analysis and data interpretation. Our method development and validation strategies are shaped by industry guidelines to provide data that is preclinically and clinically relevant and of the highest quality and value.
Support Across the Drug Development Continuum
Our team supports your program from preclinical discovery and translational research and biomarker development through clinical bioanalysis.